SCHEMBL411116

SCHEMBL411116

Cc1c(C)c(C)c2c(c1C)C(=O)N(C(CCC(=O)O)C(=O)O)C2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 3/20 0.58
KDM4E B2RXH2 2/20 0.58
HPGD P15428 2/20 0.58
HSD17B10 Q99714 2/20 0.58
TP53 P04637 1/20 0.58
GLA P06280 1/20 0.58
POLB P06746 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
ALOX12 P18054 1/20 0.58
NFKB1 P19838 1/20 0.58
APEX1 P27695 1/20 0.58
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 1/20 0.47
PPM1B O75688 1/20 0.46
GAA P10253 2/20 0.43
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14069485 0.89 POLB (0.45) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL411551 0.87 KMT2A (0.55) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL2169224 0.77 ALDH1A1 (0.70) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL9064640 0.74 ALDH1A1 (0.55) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL411110 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL14991107 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL29763164 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL411173 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL441970 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10
SCHEMBL7285516 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716314-B2 Isotopologues of thalidomide CELGENE CORPORATION (US) 2014-05-06 US disclosed
US-20120064004-A1 ISOTOPOLOGUES OF THALIDOMIDE CELGENE CORPORATION 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120064004-A1 ISOTOPOLOGUES OF THALIDOMIDE CDK4, FKBP8, FKBP1A ALDH1A1 1659/4885MAPK1 3339/4885KDM4E 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.